Phenacemide API Manufacturers & Suppliers

Phenacemide (CAS Number 63-98-9) is an anticonvulsant agent utilized in the management of epilepsy, specifically for controlling certain seizure types. It is classified chemically as a phenylacetamide, which is a subclass of amide derivatives of phenylacetic acids. Clinically, phenacemide is indicated for patients with severe epilepsy, particularly those exhibiting mixed forms of complex partial seizures, including psychomotor or temporal lobe seizures, which are refractory to other anticonvulsant therapies.

Pharmacodynamically, phenacemide functions as a ureal anticonvulsant by increasing the seizure threshold. It elevates the threshold for minimal electroshock-induced convulsions and abolishes the tonic phase of maximal electroshock seizures. Additionally, phenacemide is effective in preventing or modifying seizures induced by chemical convulsants such as pentylenetetrazol.

The primary mechanism of action of phenacemide involves its interaction with neuronal ion channels. It binds to and blocks voltage-sensitive sodium channels and calcium channels in neurons. This inhibition decreases neuronal depolarization and reduces hypersynchronization of neuronal activity—a pathological process commonly underlying seizure generation.

Regarding absorption, distribution, metabolism, and excretion (ADME) properties, specific data are limited; however, as a central nervous system depressant, phenacemide crosses the blood-brain barrier to exert its therapeutic effect. Safety considerations include potential toxicity related to central nervous system depression, with particular attention required to avoid adverse effects in vulnerable populations. Due to its mechanism and side effect profile, phenacemide has been largely superseded by newer anticonvulsants but remains a reference compound in pharmacological contexts.

Phenacemide has historical usage in epilepsy treatment with limited current commercial presence. Notable brand names have largely been phased out in favor of agents with improved safety margins.

For sourcing and quality assurance of phenacemide as an active pharmaceutical ingredient, suppliers should provide comprehensive analytical data confirming identity, purity, and compliance with pharmacopeial standards. Given its central nervous system pharmacology and narrow therapeutic index, stringent quality control is essential to ensure consistent clinical performance and patient safety.